Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Absolute Lymphocyte Count at the Time of Relapse Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma.

Luis F. Porrata, MD, Kay Ristow, Thomas M Haberman, MD, Thomas E Witzig, MD, David James Inwards, MD, Stephen M Ansell, MD, PhD, Patrick B Johnston, MD, PhD, Ivana N. Micallef, MD, Joseph P Colgan, MD, William L White, MD, Svetomir N Markovic, MD, PhD

Blood (2008) 112 (11): 1763.

https://doi.org/10.1182/blood.V112.11.1763.1763

Published: 2008

Journal Articles

Absolute Lymphocyte Count Is Independent of the Anaplastic Lymphoma Kinase and Predicts Survival in Primary Anaplastic Large Cell Lymphoma.

Luis F. Porrata, MD, Kay Ristow, Thomas E. Witzig, MD, Thomas M. Haberman, MD, David J. Inwards, MD, Stephen M. Ansell, MD, PhD, Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, Joseph Colgan, MD, William L. White, MD, Svetomir N. Markovic, MD, PhD

Blood (2007) 110 (11): 1335.

https://doi.org/10.1182/blood.V110.11.1335.1335

Published: 2007

Journal Articles

Phase II Study of Rituximab and Cladribine (2-CDA) in Newly Diagnosed Mantle Cell Lymphoma (MCL) (N0189).

David James Inwards, MD, David W. Hillman, Paul A. Fishkin, MD, William L. White, MD, Roscoe F. Morton, MD, Shaker R. Dakhil, MD, Daniel A. Nikcevich, MD,PhD, Donald B. Wender, MD, Tom R. Fitch, MD, Paul J. Kurtin, MD

Blood (2006) 108 (11): 2746.

https://doi.org/10.1182/blood.V108.11.2746.2746

Published: 2006

Journal Articles

Absolute Lymphocyte Count Recovery during Standard Chemotherapy Predicts Superior Survival and Is Independent of the Hasenclever Index for Hodgkin’s Disease.

Mustaqeem Siddiqui, MD, Luis F. Porata, MD, Kay Ristow, Thomas M. Habermann, MD, Joseph P. Colgan, MD, William L. White, MD, Thomas E. Witzig, MD, David J. Inwards, MD, Stephen M. Ansell, MD, PhD, Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, William G. Martin, MD, James A. Martenson, MD, Scott L. Stafford, MD, Svetomir N. Markovic, MD, PhD

Blood (2005) 106 (11): 2667.

https://doi.org/10.1182/blood.V106.11.2667.2667

Published: 2005

Journal Articles

Absolute Lymphocyte Count Recovery Predicts Superior Survival and Is Independent of the International Prognostic Index in Patients Treated with CHOP or R-CHOP Chemotherapy for Diffuse Large B Cell Lymphoma.

Luis F. Porrata, MD, Kay M. Ristow, Susan M. Geyer, PhD, Svetomir N. Markovic, MD, PhD, Daniel O. Persky, MD, Joseph P. Colgan, MD, William L. White, MD, Thomas E. Witzig, MD, David J. Inwards, MD, Stephen M. Ansell, MD, PhD, Ivana N. Micallef, MD, Patrick B. Johnston, MD, Thomas M. Habermann, MD

Blood (2005) 106 (11): 931.

https://doi.org/10.1182/blood.V106.11.931.931

Published: 2005

NARROW

Absolute Lymphocyte Count at the Time of Relapse Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma.

Absolute Lymphocyte Count Is Independent of the Anaplastic Lymphoma Kinase and Predicts Survival in Primary Anaplastic Large Cell Lymphoma.

Phase II Study of Rituximab and Cladribine (2-CDA) in Newly Diagnosed Mantle Cell Lymphoma (MCL) (N0189).

Absolute Lymphocyte Count Recovery during Standard Chemotherapy Predicts Superior Survival and Is Independent of the Hasenclever Index for Hodgkin’s Disease.

Absolute Lymphocyte Count Recovery Predicts Superior Survival and Is Independent of the International Prognostic Index in Patients Treated with CHOP or R-CHOP Chemotherapy for Diffuse Large B Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Absolute Lymphocyte Count at the Time of Relapse Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma.

Absolute Lymphocyte Count Is Independent of the Anaplastic Lymphoma Kinase and Predicts Survival in Primary Anaplastic Large Cell Lymphoma.

Phase II Study of Rituximab and Cladribine (2-CDA) in Newly Diagnosed Mantle Cell Lymphoma (MCL) (N0189).

Absolute Lymphocyte Count Recovery during Standard Chemotherapy Predicts Superior Survival and Is Independent of the Hasenclever Index for Hodgkin’s Disease.

Absolute Lymphocyte Count Recovery Predicts Superior Survival and Is Independent of the International Prognostic Index in Patients Treated with CHOP or R-CHOP Chemotherapy for Diffuse Large B Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only